Conformis, Inc. (CFMS) financial statements (2022 and earlier)

Company profile

Business Address 600 TECHNOLOGY DRIVE
BILLERICA, MA 01821
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:100,55628,67326,40023,60045,20065,500117,185
Cash and cash equivalents100,55628,67326,39416,38018,34837,257117,185
Short-term investments   7,24526,88028,242 
Other undisclosed cash, cash equivalents, and short-term investments  6(25)(28)1 
Receivables9,0798,51511,06613,24413,20014,67514,867
Inventory, net of allowances, customer advances and progress billings15,20412,58512,0749,5349,18411,72011,520
Inventory15,20412,58512,0749,5349,18411,72011,520
Deferred tax assets  3315
Other undisclosed current assets2,0443,5712,9741,5782,2743,9202,436
Total current assets:126,88353,34452,51447,95669,85895,848146,023
Noncurrent Assets
Operating lease, right-of-use asset7,5365,215 
Property, plant and equipment10,26812,24013,35614,43916,51415,08410,966
Intangible assets, net (including goodwill)   1096,9411,4991,748
Goodwill    6,731753753
Intangible assets, net (excluding goodwill)   109210746995
Restricted cash and investments   462462300600
Other noncurrent assets9223921117237932
Other undisclosed noncurrent assets5624626,315    
Total noncurrent assets:18,45818,15619,88215,02723,94016,96213,346
TOTAL ASSETS:145,34171,50072,39662,98393,798112,810159,369
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,13312,13114,05511,37512,61113,96612,529
Accounts payable6,5574,9186,9203,4454,8915,4744,718
Accrued liabilities9,5767,2137,1357,9307,7208,4927,811
Deferred revenue 14,000 
Debt 1,620    295
Deferred revenue and credits305305305
Contract with customer, liability2,331 
Other undisclosed current liabilities1,8303,1681,469    
Total current liabilities:17,96330,91917,85511,37512,91614,27113,129
Noncurrent Liabilities
Long-term debt and lease obligation26,82629,20919,62314,79229,667 183
Long-term debt, excluding current maturities20,35525,00319,62314,79229,667 183
Operating lease, liability6,4714,206 
Liabilities, other than long-term debt  13,5006164,6654,4844,845
Deferred revenue and credits4,0144,3204,625
Contract with customer, liability12,000 
Other liabilities  1,500616651164220
Other undisclosed noncurrent liabilities(6,471) 5,071 37  
Total noncurrent liabilities:26,82629,20938,19415,40834,3694,4845,028
Total liabilities:44,78960,12856,04926,78347,28518,75518,157
Stockholders' equity
Stockholders' equity attributable to parent100,55211,37216,34736,20046,51394,055141,212
Common stock2111   
Additional paid in capital632,513543,809521,356513,336486,570476,486467,075
Accumulated other comprehensive income (loss)(1,112)(4,000)(865)(1,470)(3,236)499(521)
Accumulated deficit(530,851)(528,438)(504,145)(475,667)(436,821)(382,930)(325,342)
Total stockholders' equity:100,55211,37216,34736,20046,51394,055141,212
TOTAL LIABILITIES AND EQUITY:145,34171,50072,39662,98393,798112,810159,369

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues99,86068,76177,42989,78978,11579,89966,887
Revenue, net78,11579,89966,887
Cost of revenue(34,179)(35,046)(40,692)(41,304)(49,301)(53,192)(42,415)
Gross profit:65,68133,71536,73748,48528,81426,70724,472
Operating expenses(68,689)(58,829)(61,866)(87,177)(84,661)(82,851)(80,433)
Operating loss:(3,008)(25,114)(25,129)(38,692)(55,847)(56,144)(55,961)
Nonoperating income (expense)(3,070)3,236(362)(1,256)4,548(1,243)346
Investment income, nonoperating9776330659491487138
Foreign currency transaction gain (loss), before tax(3,167)3,160(692)(1,915)4,057(1,607) 
Other nonoperating income (expense)     (123)208
Interest and debt expense(3,496)(2,373)(2,942)(3,356)(2,119)(138)(1,590)
Loss from continuing operations before equity method investments, income taxes:(9,574)(24,251)(28,433)(43,304)(53,418)(57,525)(57,205)
Other undisclosed income from continuing operations before income taxes7,252      
Loss from continuing operations before income taxes:(2,322)(24,251)(28,433)(43,304)(53,418)(57,525)(57,205)
Income tax expense(91)(42)(45)(61)(162)(63)(41)
Net loss available to common stockholders, diluted:(2,413)(24,293)(28,478)(43,365)(53,580)(57,588)(57,246)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(2,413)(24,293)(28,478)(43,365)(53,580)(57,588)(57,246)
Comprehensive loss:(2,413)(24,293)(28,478)(43,365)(53,580)(57,588)(57,246)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,888(3,135)6051,766(3,735)1,020(24)
Comprehensive income (loss), net of tax, attributable to parent:475(27,428)(27,873)(41,599)(57,315)(56,568)(57,270)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: